Alternatives to iDEL Therapeutics
iDEL Therapeutics is a Biotechnology tool: developing a pipeline of cancer therapeutics delivered directly into the cytosol of tumor cells. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to iDEL Therapeutics
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
Kite Pharma66BiotechnologySanta Monica, United States$421.2MBiotechnology company developing and commercializing cell therapies for cancer treatment.
- Website
Degron Therapeutics62BiotechnologySan Diego, USA$40.0MClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
- Website
Infinimmune60BiotechnologyAlameda, United States$75.0MDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
- Website
Enterome60BiotechnologyParis, France$123.9MClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
- Website
CellCentric60BiotechnologyCambridge, United Kingdom$375.0MA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
- Website
Alcolase85BiotechnologyCopenhagen, DenmarkEnzyme-based technology to break down alcohol in the stomach.
- Website
Adcendo60BiotechnologyCopenhagen, Denmark$272.0MDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
- Website
Janux Therapeutics57BiotechnologySan Diego, USA$181.0MA clinical-stage biopharmaceutical company developing novel immunotherapies.
- EAEarendil Labs56BiotechnologyBeijing, China$787.0M
Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.
- Website CRCrossbow Therapeutics55BiotechnologyCambridge, United States$157.0M
Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.
- Website
STORM Therapeutics51BiotechnologyCambridge, United Kingdom$57.6MClinical-stage biotech company targeting RNA modifications for novel cancer therapies.
- Website
Immix Biopharma, Inc.51BiotechnologyLos Angeles, United States$5.0MA clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.
- Website
ONCOMATRYX50BiotechnologyDerio, Spain$106.8MDeveloping Quantum ADCs against the tumor microenvironment for innovative cancer therapies.
- Website
Cartography Biosciences49BiotechnologySouth San Francisco, USA$150.0MA biotechnology company focused on oncology drug discovery.
- Website
LTZ Therapeutics49BiotechnologyRedwood City, USA$76.0MImmunotherapy company targeting oncology and autoimmune diseases.
- Website
Brenus Pharma48BiotechnologyLyon, France$12.6MClinical-stage immunotherapy company developing novel treatments for cancer.
- Website
AdvanCell47BiotechnologyBoston, USA$315.0MAdvancing targeted alpha therapies.
- Website
AN2 Therapeutics46BiotechnologyMenlo Park, United States$132.0MClinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.
- Website
Signadori Bio45BiotechnologyParis, France$12.2MDeveloping a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.
Showing the 20 closest matches. See the rest on the iDEL Therapeutics profile.
Compare iDEL Therapeutics head to head
Side by side on what each one does, what it costs, and what real users report.